Cyclerion Therapeutics (CYCN) Stock Chart & Stock Price History $2.58 +0.81 (+45.76%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Cyclerion Therapeutics Stock Price Performance 5 Day Performance+40.98%1 Month Performance+3.61%3 Month Performance+2.79%6 Month Performance-9.47%Year-To-Date Performance-22.99%1 Year Performance+22.27% Receive CYCN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. CYCN Stock Chart for Monday, November, 18, 2024 CYCN Chart by TradingView Cyclerion Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$1.77$2.58+45.76%$2.99$1.7611.98 million shs$6.99 million11/14/2024$1.83$1.77-3.28%$1.83$1.7128,114 shs$4.80 million11/13/2024$1.81$1.83+1.10%$2.01$1.7751,247 shs$4.96 million11/12/2024$2.56$1.81-29.30%$2.63$1.7171,630 shs$4.91 million11/11/2024$2.53$2.56+1.19%$2.76$2.4710,370 shs$6.94 million11/08/2024$2.48$2.67+7.66%$2.72$2.5011,726 shs$7.24 million Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$2.60$2.48-4.62%$2.80$2.4614,259 shs$6.72 million11/06/2024$2.70$2.60-3.70%$2.79$2.6021,034 shs$7.05 million11/05/2024$2.64$2.70+2.27%$2.99$2.6437,953 shs$7.32 million11/04/2024$2.95$2.64-10.51%$3.15$2.3296,568 shs$7.15 million11/01/2024$2.89$2.95+2.08%$3.74$2.88124,916 shs$8.00 million10/31/2024$3.08$2.89-6.17%$3.39$2.6450,745 shs$7.83 million10/30/2024$3.03$3.08+1.65%$3.47$2.9959,745 shs$8.35 million10/29/2024$3.07$3.03-1.30%$4.13$3.03104,359 shs$8.21 million10/28/2024$3.03$3.07+1.32%$3.16$3.051,272 shs$8.32 million10/25/2024$3.00$3.08+2.67%$3.17$3.0020,303 shs$8.35 million10/24/2024$2.92$3.00+2.74%$3.08$2.859,635 shs$8.13 million10/23/2024$2.84$2.92+2.82%$3.00$2.7119,426 shs$7.91 million10/22/2024$2.90$2.84-2.07%$3.00$2.8012,408 shs$7.70 million10/21/2024$2.50$2.90+16.00%$2.91$2.3524,182 shs$7.86 million10/18/2024$2.65$2.49-6.04%$2.77$2.3520,451 shs$6.75 million10/17/2024$2.44$2.65+8.61%$2.65$2.2928,084 shs$6.83 million Related Companies ORGS Stock Chart OBSV Stock Chart MRNS Stock Chart CVKD Stock Chart NNVC Stock Chart CARA Stock Chart APRE Stock Chart FNCH Stock Chart COCP Stock Chart TXMD Stock Chart Receive CYCN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCN) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclerion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
